Skip to main content
Equibles
EXEL logo

EXEL · Exelixis, Inc.

Track EXEL — free

Use EXEL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$59.01 -0.12 (-0.20%) At close · Sep 4
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$14.62B
Shares
247.78M

EXEL metrics

79 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$59.01
Market cap
$14.62B

Price action

19 metrics
Price change (1W)
+8.4%
Price change (30D)
+9.1%
Price change (3M)
+12.0%
Price change (6M)
+42.0%
Price change (YTD)
+34.6%
Price change (1Y)
+57.9%
Trailing year
Price change (5Y)
+198.5%
52-week high
$59.13
52-week low
$34.54
Change from 52-week high
-0.2%
Change from 52-week low
+70.8%
Annualized volatility
36.9%
Beta
0.6
RSI (14D)
64.5
Price vs SMA 50
+7.2%
Price vs SMA 200
+23.8%
Avg volume (3M)
2.54M
Relative volume
0.6
Average dollar volume
$137.91M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
247.78M

Valuation

12 metrics
P / E (TTM)
18.5
Trailing earnings · reciprocal yield 5.4%
PEG ratio
0.7
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.0×
reciprocal yield 16.7%
P / book
7.9
reciprocal yield 12.6%
FCF yield
8.0%
TTM · current market cap
Buyback yield
7.6%
P / FCF
12.5
reciprocal yield 8.0%
P / operating cash flow
12.4
reciprocal yield 8.1%
Earnings yield
5.9%

Historical valuation

8 metrics
P / E historical average (3Y)
25.6×
reciprocal yield 3.9%
P / E historical average (5Y)
29.1×
reciprocal yield 3.4%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
7.6%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
96.4%
Operating margin
39.9%
Trailing 12 months
Net margin
35.3%
Gross profit (TTM)
$705.28M
Operating profit (TTM)
$971.51M
Net income (TTM)
$860.62M
Trailing 12 months
Diluted EPS (TTM)
$3.19
FCF margin
48.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-2.09

Growth

11 metrics
Revenue growth YoY
+10.6%
Year over year
Net income growth YoY
+14.7%
Revenue (TTM)
$2.44B
Trailing 12 months
EPS growth YoY
+26.2%
Shares change YoY
-8.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+12.9%
Revenue CAGR (5Y)
+18.6%
EPS CAGR (3Y)
+70.6%
EPS CAGR (5Y)
+51.4%
FCF CAGR (3Y)
+37.8%
FCF CAGR (5Y)
+37.4%

Quality

14 metrics
Return on equity
46.7%
Return on assets
34.5%
Debt / equity
—
Current ratio
3.5
EBITDA (TTM)
$999.81M
Free cash flow (TTM)
$1.17B
Quick ratio
3.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$281.45M
Total assets
$2.49B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.18B
Capital expenditures (TTM)
$10.96M
R&D (TTM)
$824.32M
SG&A (TTM)
$533.92M
Stock compensation (TTM)
$112.59M
R&D / revenue
33.8%
Stock compensation / revenue
4.6%

Ownership (13F)

3 metrics
13F filers
760
13F filer change QoQ
+53
Institutional ownership
105.2%

Short interest

3 metrics
Short interest
11.3%
Latest settlement · 8.7 days to cover
Days to cover
8.7d
Short-squeeze score
73 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$526,512
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 939767 CUSIP 30161Q104 13F (30d) 458 filings 429 filers Visit website Investor relations